Sarfez Pharmaceuticals, Inc.
Quick facts
Marketed products
- Immedate Release Torsemide Tablets · Cardiovascular
Torsemide is a loop diuretic that inhibits sodium and chloride reabsorption in the ascending limb of the loop of Henle, promoting urinary excretion of water and electrolytes.
Phase 3 pipeline
- Torsemide and Spironolactone tablet · Cardiovascular
Torsemide is a loop diuretic that works by inhibiting the sodium-potassium-chloride cotransporter in the ascending limb of the loop of Henle, while spironolactone is a potassium-sparing diuretic that works by antagonizing the aldosterone receptor. - Torsemide Tablets and Spironolactone Tablets · Cardiovascular
Torsemide is a thiazide-like diuretic that works by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys, leading to increased urine production and reduced fluid volume. Spironolactone is a potassium-sparing diuretic that works by antagonizing the mineralocorticoid receptor, leading to increased sodium excretion and reduced potassium loss.
Phase 2 pipeline
- Extended release torsemide · Cardiovascular
Torsemide is a loop diuretic that works by inhibiting the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle in the kidneys. - Immediate release torsemide · Cardiovascular
Inhibits the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: